Non-invasive Glioma Characterization Through Molecular Imaging
Recruiting
Pilot Study for Non-invasive Glioma Characterization Through Molecular Imaging
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Adults (≥18 year old) * Subjects with suspected or confirmed gliomas and who will have a medically indicated biopsy or resection of his/her brain lesion. Exclusion Criteria: * Adults unable to consent * Individuals who are not yet adults (infants, children, teenagers) * Pregnant women * Patients unable to have MRI done
About the study
MRI-based sequences can provide non-invasive quantification of intratumoral 2-hydroxyglutarate (2HG) distribution and tumor cellularity in human gliomas and help guide the development of novel glioma therapies.
What is being tested
- 3T MRI Scanner (device)
Sponsor: University of Miami · Participants: 30 · Started: Jan 25, 2019
Contact the study team
- Nathalie Padron · Phone: 305-243-3530
Official record on ClinicalTrials.gov — NCT03684109
Locations in the U.S.
| Florida | University of Miami, Miami |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.